I2113F (p.Ile2113Phe) variant of MYO15A (Unconventional myosin-XV)
I2113F (p.Ile2113Phe) in MYO15A (Unconventional myosin-XV) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Nonsyndromic genetic hearing loss. The available variant effect predictions contribute to a CATVariant prioritization score of 0.84 / 1. The record also includes published literature and structural context.
I2113F (p.Ile2113Phe) variant details
- p.Ile2113Phe
- rs121908965
- ClinGen CA254013
- ClinVar RCV000007365
- ClinVar RCV002228014
- Likely pathogenic
- Nonsyndromic genetic hearing loss
- Missense
- Variant Prioritization Score for Impact Estimate 0.838
- ESM-1b 1.00
- AlphaMissense 0.54
- MetaLR 0.91
- MetaSVM 1.02
- PolyPhen-2 1.00
- SIFT 0.00
- ClinVar: Likely pathogenic (Nonsyndromic genetic hearing loss)
- EBI: Pathogenic (in DFNB3)
- UniProt: Pathogenic (in DFNB3)
- Structural context available
- Cited in: A gene for congenital, recessive deafness DFNB3 maps to the pericentromeric region of chromosome 17. (PMID 7704031)
- Cited in: Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3. (PMID 9603736)